Perkins researchers find gene for deadliest breast cancer
By Alicia Bienkowski | Breast Cancer, Breast Cancer, Cancer, Cancer Epigenetics, Genes, Lab, Media Releases, News & EventsA new cancer-causing gene and protein which creates highly aggressive hard to treat breast cancers has been discovered by cancer researchers at the Harry Perkins Institute. The discovery has been…
Waking up silent genes
By Alicia Bienkowski | Cancer Epigenetics, Genes, Genetic Disease, Lab, News & Events, ResearchTesting proven cancer research on a devastating childhood condition For parents whose child has been diagnosed with Prader-Willi Syndrome (PWS), their concerns usually start when their baby fails to thrive.…
Cancer researcher inspired by nature to kill cancer
By Alicia Bienkowski | Breast Cancer, Breast Cancer, Cancer Epigenetics, Lab, News & Events, Research, Walk for Women's CancerA WA discovery made global news when venom from honeybees was found to kill aggressive breast cancer cells. Associate Professor and Wesfarmers Fellow, Dr Pilar Blancafort, from the Harry Perkins…
Honeybee venom kills breast cancer cells
By Alicia Bienkowski | Breast Cancer, Breast Cancer, Cancer, Cancer Epigenetics, Lab, Media Releases, News & Events, ResearchVenom from honeybees found to kill aggressive breast cancer cells – Australian research published in Nature Precision Oncology Honeybee venom induces cancer cell death in hard to treat triple-negative breast cancer with minimal effect on healthy cells. Using…
Activating the silent assassin within to fight breast cancer
By Alicia Bienkowski | Cancer, Cancer, Cancer Epigenetics, Funding, Media Releases, News & EventsPerth researcher wins $1.4m grant to wake up an immune system corrupted by cancer FAST FACTS: Breast cancer is the second most common cancer in women globally 14 million women…
Brain & Breast Cancer Collaborative Grant Recipient Announced
By Alicia Bienkowski | Brain, Breast Cancer, Cancer, Cancer Epigenetics, Genes, News & Events, ResearchProject led by Associate Professor Pilar Blancafort will be co-funded by an $890,000 investment from Cure Brain Cancer Foundation and National Breast Cancer Foundation. Top researchers from the fields of…
Personalised medicine using nanoparticles for breast cancer treatment
By Marlin Communications | Breast Cancer, Cancer and Cell Biology, Cancer Epigenetics, Disease Area, Lab, News & Events, Research, Research AreaAt the Harry Perkins Institute of Medical Research, a Cancer Epigenetics team is investigating ways to leverage the great opportunities that nanotechnology offers in the treatment of one of the…
New method to fight hard to treat breast cancers
By Marlin Communications | Breast Cancer, Cancer and Cell Biology, Cancer Epigenetics, Disease Area, Lab, News & Events, Research, Research AreaThe research led by Perkins researcher Dr Anabel Sorolla involves the use of nanoparticles to deliver a series of anti-cancer agents directly to the tumour. The study focused on triple…